You are here

Resolution of serum and cerebrospinal fluid abnormalities after treatment of neurosyphilis. Influence of concomitant human immunodeficiency virus infection.

TitleResolution of serum and cerebrospinal fluid abnormalities after treatment of neurosyphilis. Influence of concomitant human immunodeficiency virus infection.
Publication TypeJournal Article
Year of Publication1996
AuthorsMarra, CM, Longstreth, WT, Maxwell, CL, Lukehart, SA
JournalSex Transm Dis
Volume23
Issue3
Pagination184-9
Date Published1996 May-Jun
ISSN0148-5717
KeywordsAntibodies, Bacterial, Cerebrospinal Fluid Proteins, HIV Infections, Humans, Lymphocyte Count, Neurosyphilis, Penicillins, Time Factors, Treatment Outcome, Treponema pallidum
Abstract

BACKGROUND AND OBJECTIVES: Little is known about resolution of serum and cerebrospinal fluid abnormalities after neurosyphilis treatment, especially in patients infected with human immunodeficiency virus (HIV).

GOAL: To examine the time course of resolution of these abnormalities.

STUDY DESIGN: Case series of 22 patients with neurosyphilis (13 infected with HIV) with reactive cerebrospinal fluid Venereal Disease Research Laboratory test who underwent at least one lumbar puncture after treatment.

RESULTS: Resolution of all serum and cerebrospinal fluid measures was slower in patients infected with HIV. Serum and cerebrospinal fluid abnormalities resolved in most patients not infected with HIV by 30 weeks, and all met Centers for Disease Control and Prevention criteria for cure. One patient infected with HIV failed therapy by Centers for Disease Control and Prevention criteria, and three others had persistent pleocytosis.

CONCLUSIONS: HIV-infected patients with neurosyphilis have slower resolution of serum and cerebrospinal fluid abnormalities after therapy. This observation may suggest impaired clearance of Treponema pallidum from the central nervous system.

Alternate JournalSex Transm Dis
PubMed ID8724507
Grant ListAI 18988 / AI / NIAID NIH HHS / United States
AI 31448 / AI / NIAID NIH HHS / United States
NS 23677 / NS / NINDS NIH HHS / United States